Did this trade today on AAPL
- John Falcone
- Oct 27, 2022
- 1 min read
Let’s see how it works out after earnings.


Let’s see how it works out after earnings.
OSRH: +170% Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
Comentarios